lorazepam has been researched along with dextropropoxyphene in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (10.00) | 18.7374 |
1990's | 1 (10.00) | 18.2507 |
2000's | 5 (50.00) | 29.6817 |
2010's | 3 (30.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Abernethy, DR; Greenblatt, DJ; Morse, DS; Shader, RI | 1 |
Hanks, GW; O'Neill, WM; Simpson, P; Wesnes, K; White, L | 1 |
Fallon, MT; Hanks, GW; Jenkins, E; O'Neill, WM; Simpson, P; Wesnes, K | 1 |
Goldman, RE; Zacny, JP | 1 |
1 review(s) available for lorazepam and dextropropoxyphene
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
4 trial(s) available for lorazepam and dextropropoxyphene
Article | Year |
---|---|
Interaction of propoxyphene with diazepam, alprazolam and lorazepam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Benzodiazepines; Dextropropoxyphene; Diazepam; Drug Interactions; Female; Half-Life; Humans; Kinetics; Lorazepam; Male; Metabolic Clearance Rate; Middle Aged | 1985 |
The cognitive and psychomotor effects of opioid analgesics. I. A randomized controlled trial of single doses of dextropropoxyphene, lorazepam and placebo in healthy subjects.
Topics: Adult; Analgesics, Opioid; Anti-Anxiety Agents; Arousal; Cognition; Cross-Over Studies; Dextropropoxyphene; Double-Blind Method; Female; Flicker Fusion; Humans; Lorazepam; Male; Memory; Mental Recall; Middle Aged; Psychomotor Performance; Reaction Time | 1995 |
The cognitive and psychomotor effects of morphine in healthy subjects: a randomized controlled trial of repeated (four) oral doses of dextropropoxyphene, morphine, lorazepam and placebo.
Topics: Adult; Analgesics, Opioid; Anti-Anxiety Agents; Arousal; Cognition; Cross-Over Studies; Dextropropoxyphene; Double-Blind Method; Female; Flicker Fusion; Humans; Lorazepam; Male; Memory; Mental Recall; Morphine; Psychomotor Performance; Reaction Time; Time Factors | 2000 |
Characterizing the subjective, psychomotor, and physiological effects of oral propoxyphene in non-drug-abusing volunteers.
Topics: Adult; Anticonvulsants; Cognition; Cross-Over Studies; Dextropropoxyphene; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Lorazepam; Lysergic Acid Diethylamide; Male; Miosis; Morphine; Narcotics; Psychomotor Performance | 2004 |
5 other study(ies) available for lorazepam and dextropropoxyphene
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |